Wed. 8 May 2024, 5:05pm ET
Benzinga
Earnings, Earnings Misses, News
Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 20 percent increase over losses of $(0.70) per share from the same period last year.